5019 Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer – a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)

✍ Scribed by C. Rochlitz; R. von Moos; M. Mannhart-Harms; R. Winterhalder; D. Rauch; A. Müller; K. Zaman; S. Lerch; M. Mayer; F. Zappa

• Book ID: 119600669
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70911-5